Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/9763
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPatel, Shreya Himanshubhai-
dc.date.accessioned2021-02-11T11:22:48Z-
dc.date.available2021-02-11T11:22:48Z-
dc.date.issued2020-07-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/9763-
dc.descriptionGuided by Dr. Snehal patel and Co-guide Ms. Palak Parikhen_US
dc.publisherInstitute of Pharmacy, Nirma University, A'baden_US
dc.relation.ispartofseriesPPR01007;-
dc.subjectPPR01007en_US
dc.subjectB. Pharm Project Reporten_US
dc.subjectPharmacologyen_US
dc.subjectDiabetesen_US
dc.subjectTyrosine Kinaseen_US
dc.subjectdiabetes mellitusen_US
dc.titleRole of Tyrosine Kinase Inhibitors in Type 2 Diabetes Mellitusen_US
dc.typeProject Reporten_US
Appears in Collections:B. Pharm Project Reports

Files in This Item:
File Description SizeFormat 
PPR01007.pdfPPR010071.56 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.